Published on 09/07/2021
12-15 November, 2021 Hybrid edition
ENYO Pharma will attend the 2021 edition of AASLD / The Liver meeting.
ENYO Pharma announces completion of Series C financing with Vesalius Biocapital and continued progress of its ALPESTRIA-1 clinical Phase 2 study in Alport syndrome patients. > Read more
Latest Press Release 